These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34598317)

  • 1. Rapalogs induce non-apoptotic, autophagy-dependent cell death in HPV-negative TP53 mutant head and neck squamous cell carcinoma.
    Alam MM; Marin Fermin J; Spiller PT; Burnett C; Rong X; Moore-Medlin T; Maxwell CO; Khandelwal AR; Nathan CO
    Mol Carcinog; 2022 Jan; 61(1):33-44. PubMed ID: 34598317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-aza-2'-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line.
    Miari R; Azzam N; Bar-Shalom R; Fares F
    PLoS One; 2021; 16(9):e0253756. PubMed ID: 34534222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.
    Ganci F; Pulito C; Valsoni S; Sacconi A; Turco C; Vahabi M; Manciocco V; Mazza EMC; Meens J; Karamboulas C; Nichols AC; Covello R; Pellini R; Spriano G; Sanguineti G; Muti P; Bicciato S; Ailles L; Strano S; Fontemaggi G; Blandino G
    Clin Cancer Res; 2020 Jun; 26(12):2956-2971. PubMed ID: 31969334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in
    Alam MM; Fermin JM; Knackstedt M; Noonan MJ; Powell T; Goodreau L; Daniel EK; Rong X; Moore-Medlin T; Khandelwal AR; Nathan CO
    Oncotarget; 2023 Feb; 14():85-95. PubMed ID: 36745547
    [No Abstract]   [Full Text] [Related]  

  • 5. PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer.
    Herzog A; Bian Y; Vander Broek R; Hall B; Coupar J; Cheng H; Sowers AL; Cook JD; Mitchell JB; Chen Z; Kulkarni AB; Van Waes C
    Clin Cancer Res; 2013 Jul; 19(14):3808-19. PubMed ID: 23640975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma.
    Chou MH; Chuang HC; Lin YT; Tsai MH; Kao YH; Lin IC; Huang TL; Fang FM; Chien CY
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAcylation stabilizes the autophagy-initiating kinase ULK1 by inhibiting chaperone-mediated autophagy upon HPV infection.
    Shi Y; Yan S; Shao GC; Wang J; Jian YP; Liu B; Yuan Y; Qin K; Nai S; Huang X; Wang Y; Chen Z; Chen X; Dong MQ; Geng Y; Xu ZX; Li J
    J Biol Chem; 2022 Sep; 298(9):102341. PubMed ID: 35931119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
    van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH
    Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR inhibitor RAD001 (everolimus) induces apoptotic, not autophagic cell death, in human nasopharyngeal carcinoma cells.
    Cai Y; Xia Q; Su Q; Luo R; Sun Y; Shi Y; Jiang W
    Int J Mol Med; 2013 Apr; 31(4):904-12. PubMed ID: 23426850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21
    Yadav M; Kandhari K; Mathan SV; Ali M; Singh RP
    Mol Carcinog; 2024 Sep; 63(9):1697-1711. PubMed ID: 38801393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV
    Xiao R; An Y; Ye W; Derakhshan A; Cheng H; Yang X; Allen C; Chen Z; Schmitt NC; Van Waes C
    Clin Cancer Res; 2019 Nov; 25(21):6463-6474. PubMed ID: 31266830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma.
    Chen W; Huang F; Huang J; Li Y; Peng J; Zhuang Y; Huang X; Lu L; Zhu Z; Zhang S
    J Gene Med; 2021 Sep; 23(9):e3364. PubMed ID: 34010493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
    Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
    Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
    Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCC.
    Aderhold C; Faber A; Umbreit C; Birk R; Weiss C; Sommer JU; Hörmann K; Schultz JD
    Anticancer Res; 2015 Apr; 35(4):1951-9. PubMed ID: 25862847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
    Park YM; Go YY; Shin SH; Cho JG; Woo JS; Song JJ
    PLoS One; 2018; 13(9):e0203069. PubMed ID: 30212479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk
    Tanaka N; Patel AA; Tang L; Silver NL; Lindemann A; Takahashi H; Jaksik R; Rao X; Kalu NN; Chen TC; Wang J; Frederick MJ; Johnson F; Gleber-Netto FO; Fu S; Kimmel M; Wang J; Hittelman WN; Pickering CR; Myers JN; Osman AA
    Clin Cancer Res; 2017 Nov; 23(21):6541-6554. PubMed ID: 28790110
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.
    Wu X; Yeerna H; Goto Y; Ando T; Wu VH; Zhang X; Wang Z; Amornphimoltham P; Murphy AN; Tamayo P; Chen Q; Lippman SM; Gutkind JS
    Cancer Res; 2019 Sep; 79(17):4360-4370. PubMed ID: 31292160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.
    Pifer PM; Yang L; Kumar M; Xie T; Frederick M; Hefner A; Beadle B; Molkentine D; Molkentine J; Dhawan A; Abdelhakiem M; Osman AA; Leibowitz BJ; Myers JN; Pickering CR; Sandulache VC; Heymach J; Skinner HD
    Clin Cancer Res; 2024 Jan; 30(1):187-197. PubMed ID: 37819945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
    Xie J; Li Q; Ding X; Gao Y
    Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.